Latest filing published 21 Nov 2022 for Aerie Pharmaceuticals INC, €3.2M.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Filings by Raj Kannan span 2 companies, the busiest being Chiasma, Inc and Aerie Pharmaceuticals Inc. Over a trading history stretching from 14 July 2020 to 21 November 2022, the count stands at 5 filings.
Purchases make up the whole of the open-market record (2 purchases, €442k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 share grant.
The newest entry dates from 21 November 2022: a transaction of €3.2M, in Aerie Pharmaceuticals Inc. The latest purchase dates back some time: it was published 2,160 days ago, on 24 November 2020. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations